Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Bullboard Posts
Comment by LifeGoesOn1973on Jun 05, 2018 11:38am
135 Views
Post# 28126214

RE:point 3 in Georges letter

RE:point 3 in Georges letter
jpinkman wrote:
3. MD Anderson is not just a hopsital but a network of several hospitals who see 1.5M patients per year and perform almost 600,000 imaging studies. This network would need 750 VMS+ devices to treat their patients according to the AHA guidelines (3 scans per patient) at full utilization.  Many survey’s have shown ultrasound equipment is used only 50% to 60% of the capacity due to scheduling and other issues, so in reality they would need 1,500 machines just for their network.  The chief cardiologists will be using the VMS+ initially in the main hospital in Houston to get a good understanding of how it works and how it can be used in all their hospitals.


are you saying that this order is for 1500 Machine VMS+?
Bullboard Posts